Niacinamide

1. INCI et CAS

INCI: Niacinamide · CAS: 98-92-0

2. Rôle dans la formule

Niacinamide is widely used in leave-on cosmetic guides around 2–5%. This is not a drug monograph claim and not a whitening drug claim.

3. Niveaux d'emploi typiques (repère de formulation)

• The formulation record indicates 2–5% for serums as a formulation guide.
• For gel-creams, the recorded level is 2–4% for the formula.
• For toners, the reference gives 2–3%.

For dissolution, use the water phase. Keep finished pH roughly 5–6.5 so it stays in the cosmetic range used by formulators.

4. Sources réglementaires et conformité mondiale

• CosIng provides reference information for Niacinamide; confirm the specific grade and intended use against market requirements.
• Before EU placement, Regulation (EC) No 1223/2009 requires the final cosmetic with Niacinamide to undergo a safety assessment for the product in its final form.
• Review the supplier TDS for the received Niacinamide grade, together with the target market's current filing requirements.

5. Sécurité et évaluation des risques

The concentration shown is guidance for cosmetic formulation; it does not establish drug approval or OTC-monograph status and patch and stability testing remain part of finished-product review.

6. Stabilité et conditionnement

Keep the ingredient in cool, closed bulk storage away from sunlight; review airless or pump options if oxidation presents a concern; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic formulation concept for Niacinamide centers on niacinamide conditioning.

• This product entry does not substantiate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The ingredient record for Niacinamide cannot verify whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.

1. INCI et CAS

INCI: Glycerin · CAS: 56-81-5

2. Rôle dans la formule

Glycerin serves as the polyol humectant in these cosmetic formats, while the stated percentage remains a formulation reference.

3. Niveaux d'emploi typiques (repère de formulation)

• The formulation record indicates 3–8% for gels and serums in this reference.
• 2–5% is listed for creams for the formula.
• 2–4% is listed for rinse-off as a formulation guide.

The guide places Glycerin in the water phase and calls for no melt step.

4. Sources réglementaires et conformité mondiale

• Database information on Glycerin does not replace review of the supplied grade and finished product under market rules.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Glycerin before the finished product is marketed.
• Review the documentation for the actual Glycerin grade and the filing requirements for the target market.

5. Sécurité et évaluation des risques

Use the stated level as reference guidance for cosmetic formulation; it should not be read as a drug authorization or OTC listing so patch response and stability should be checked on the finished product.

6. Stabilité et conditionnement

Maintain cool, closed, light-protected storage for the bulk material; choose a package with oxidation sensitivity in view; use batch testing to verify stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Glycerin's cosmetic direction around humectant function.

• This ingredient reference provides no basis for a drug effect, a clinical cure, or certification status not established for the SKU.
• The information about Glycerin cannot establish whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

A plant-derived grade of squalane is specified here. It is a stable hydrocarbon emollient and is distinct from mineral oil.

3. Niveaux d'emploi typiques (repère de formulation)

• Gel-creams may use the guide range 2–6% for the formula.
• The formulation record indicates 10–30% for dry oils in this reference.
• The formulation record indicates 5–15% for balms in this reference.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Sources réglementaires et conformité mondiale

• The CosIng record for Squalane, where listed, is informational rather than product-specific authorization.
• The framework in Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Squalane for the complete formula intended for sale.
• Review the supplier TDS for the received Squalane grade, together with the target market's current filing requirements.

5. Sécurité et évaluation des risques

The guide records a level for cosmetic formulation purposes; it provides no evidence that a drug or OTC monograph applies and the finished formula still needs patch and stability testing.

6. Stabilité et conditionnement

For bulk storage, avoid warmth and direct sun and keep the container closed; match the pack choice to the system's oxidation risk; verify the chosen pack against the tested formula.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Squalane's cosmetic direction around a light-emollient role.

• The available ingredient details is not evidence of drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• This Squalane listing offers no support for whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.